Hikma Sues Eagle Over $3.5M Generic-Drug Rights Deal
Hikma Pharmaceuticals LLC sued Eagle Pharmaceuticals Inc. in New York federal court Monday, alleging Eagle had failed to win timely regulatory approval as required under a $3.5 million generic-drug rights transfer...To view the full article, register now.
Already a subscriber? Click here to view full article